ANAFRANIL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Poland, Romania, Singapore, Tunisia, Turkey, United States, South Africa

Active ingredients

The drug ANAFRANIL contains one active pharmaceutical ingredient (API):

1 Clomipramine UNII 2LXW0L6GWJ - CLOMIPRAMINE HYDROCHLORIDE

The therapeutic activity of clomipramine is believed to be based on its ability to inhibit the neuronal re-uptake of noradrenaline (NA) and serotonin (5-HT) released in the synaptic cleft, with inhibition of 5-HT reuptake being the more important of these activities. Read about Clomipramine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ANAFRANIL Prolonged-release, film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AA04	Clomipramine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1561E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526500902114311, 526501001110314, 526517040088403, 526517040088503
Country: CA	Health Products and Food Branch	Identifier(s): 00324019, 00330566, 00402591
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 04954736, 04954742, 07152753, 07152776, 07152782, 07356970, 07356987, 07448896, 07478354, 11024860, 16847655
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.785-10-02
Country: EE	Ravimiamet	Identifier(s): 1001462, 1011407, 1011418, 1636073
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 44656, 44657, 49656, 57568
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 074192, 102503, 476462
Country: FR	Base de données publique des médicaments	Identifier(s): 61426025, 69235342, 69273510, 69281119
Country: HK	Department of Health Drug Office	Identifier(s): 45537, 45562
Country: IE	Health Products Regulatory Authority	Identifier(s): 14389
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3534, 516
Country: JP	医薬品医療機器総合機構	Identifier(s): 1174002F1029, 1174002F2025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000126
Country: MT	Medicines Authority	Identifier(s): MA1423/00101, MA1423/00102, MA1423/00103, PI1438/11101A, PI1438/11102A, PI908/02601C, PI908/02602C
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 69402, 84M83
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100005632, 100005649, 100005655
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67624001, W67625001
Country: SG	Health Sciences Authority	Identifier(s): 07533P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 17543011, 17543012, 17543013, 17543014
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699529030036, 8699529120010, 8699529120027
Country: US	FDA, National Drug Code	Identifier(s): 0406-9906, 0406-9907, 0406-9908
Country: ZA	Health Products Regulatory Authority	Identifier(s): C/1.2/182, W/1.2/140